L. Bergstrand

796 total citations
23 papers, 619 citations indexed

About

L. Bergstrand is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, L. Bergstrand has authored 23 papers receiving a total of 619 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 7 papers in Cardiology and Cardiovascular Medicine and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in L. Bergstrand's work include Lipoproteins and Cardiovascular Health (7 papers), Cardiac Imaging and Diagnostics (6 papers) and Coronary Interventions and Diagnostics (5 papers). L. Bergstrand is often cited by papers focused on Lipoproteins and Cardiovascular Health (7 papers), Cardiac Imaging and Diagnostics (6 papers) and Coronary Interventions and Diagnostics (5 papers). L. Bergstrand collaborates with scholars based in Sweden, United Kingdom and Denmark. L. Bergstrand's co-authors include Örjan Smedby, Uno Erikson, Ingar Holme, Göran Walldius, Anders Olsson, Jan Johansson, Liselotte Schäfer Elinder, Jörgen Mölgaard, Sven Nilsson and Anders Hamsten and has published in prestigious journals such as Arteriosclerosis Thrombosis and Vascular Biology, The American Journal of Cardiology and American Heart Journal.

In The Last Decade

L. Bergstrand

23 papers receiving 602 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Bergstrand Sweden 10 226 176 125 116 88 23 619
Diethard Pruefer Germany 12 346 1.5× 202 1.1× 83 0.7× 46 0.4× 93 1.1× 23 731
Martin F. Reiner Switzerland 17 100 0.4× 128 0.7× 85 0.7× 48 0.4× 94 1.1× 47 697
Goro Kajiyama Japan 14 227 1.0× 123 0.7× 172 1.4× 35 0.3× 66 0.8× 20 624
C B Marenah United Kingdom 17 289 1.3× 76 0.4× 88 0.7× 45 0.4× 37 0.4× 30 670
Shinichi Mashiba Japan 15 155 0.7× 105 0.6× 55 0.4× 41 0.4× 50 0.6× 20 516
Anand Prasad United States 11 336 1.5× 119 0.7× 219 1.8× 51 0.4× 110 1.3× 39 613
D Sacco United States 6 503 2.2× 282 1.6× 187 1.5× 45 0.4× 123 1.4× 11 859
Carlo Giammarresi Italy 11 298 1.3× 318 1.8× 63 0.5× 29 0.3× 78 0.9× 26 661
Birgit Svensson Norway 14 203 0.9× 169 1.0× 49 0.4× 34 0.3× 35 0.4× 29 623
K. Winkler Germany 16 318 1.4× 89 0.5× 69 0.6× 45 0.4× 36 0.4× 44 683

Countries citing papers authored by L. Bergstrand

Since Specialization
Citations

This map shows the geographic impact of L. Bergstrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Bergstrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Bergstrand more than expected).

Fields of papers citing papers by L. Bergstrand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Bergstrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Bergstrand. The network helps show where L. Bergstrand may publish in the future.

Co-authorship network of co-authors of L. Bergstrand

This figure shows the co-authorship network connecting the top 25 collaborators of L. Bergstrand. A scholar is included among the top collaborators of L. Bergstrand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Bergstrand. L. Bergstrand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Samnegård, Ann, Angela Silveira, Pia Lundman, et al.. (2005). Serum matrix metalloproteinase‐3 concentration is influenced by MMP‐3 −1612 5A/6A promoter genotype and associated with myocardial infarction. Journal of Internal Medicine. 258(5). 411–419. 96 indexed citations
3.
Johanson, Per, Lars Wallentin, Tage Nilsson, et al.. (2004). ST-segment analyses and residual thrombi in the infarct-related artery: a report from the ASSENT PLUS ST-monitoring substudy. American Heart Journal. 147(5). 853–858. 7 indexed citations
4.
Eriksson, Per, Hiroyuki Deguchi, Ann Samnegård, et al.. (2004). Human Evidence That the Cystatin C Gene Is Implicated in Focal Progression of Coronary Artery Disease. Arteriosclerosis Thrombosis and Vascular Biology. 24(3). 551–557. 82 indexed citations
5.
8.
Cederlund, Kerstin, et al.. (2001). Thin-section CT vs spiral CT in candidates for lung volume reduction surgery: a comparison based on radiologists' subjective preferences. European Radiology. 11(3). 402–408. 3 indexed citations
9.
Nilsson, S., et al.. (2001). Allergic reactions at repeat femoral angiography with ioxaglate. Acta Radiologica. 42(6). 608–611. 3 indexed citations
10.
Ericsson, Christer, et al.. (2000). Diabetes mellitus is a strong negative prognostic factor in patients with myocardial infarction treated with thrombolytic therapy. Journal of Internal Medicine. 248(2). 119–125. 14 indexed citations
11.
Blombäck, Margareta, Angela Silveira, Björn Wiman, et al.. (2000). Haemostatic Function in Patients Undergoing Coronary Artery Bypass Grafting. Thrombosis Research. 98(1). 39–49. 29 indexed citations
12.
Smedby, Örjan & L. Bergstrand. (1996). Tortuosity and atherosclerosis in the femoral artery: What is cause and what is effect?. Annals of Biomedical Engineering. 24(4). 474–480. 60 indexed citations
13.
Johansson, Jan, Anders Olsson, L. Bergstrand, et al.. (1995). Lowering of HDL 2b by Probucol Partly Explains the Failure of the Drug to Affect Femoral Atherosclerosis in Subjects With Hypercholesterolemia. Arteriosclerosis Thrombosis and Vascular Biology. 15(8). 1049–1056. 66 indexed citations
14.
Walldius, Göran, Uno Erikson, Anders Olsson, et al.. (1994). The effect of probucol on femoral atherosclerosis: The Probucol Quantitative Regression Swedish Trial (PQRST). The American Journal of Cardiology. 74(9). 875–883. 180 indexed citations
15.
Bergstrand, L., Anders Olsson, Uno Erikson, et al.. (1994). The relation of coronary and peripheral arterial disease to the severity of femoral atherosclerosis in hypercholesterolaemia. Journal of Internal Medicine. 236(4). 367–375. 14 indexed citations
16.
Bergstrand, L., Håkan Bylund, Uno Erikson, et al.. (1994). Distribution of Coronary Atherosclerosis and its Correlation to Metabolic Risk Factors and Femoral Atherosclerosis. Acta Radiologica. 35(5). 481–486. 2 indexed citations
18.
Bergstrand, L., et al.. (1993). Reproducibility of Quantitative Arteriographic Assessment of Atherosclerosis in the Femoral Artery. Acta Radiologica. 34(6). 612–617. 2 indexed citations
19.
Bergstrand, L., Uno Erikson, Ingar Holme, et al.. (1993). Reproducibility of Quantitative Arteriographic Assessment of Atherosclerosis in the Femoral Artery. Acta Radiologica. 34(6). 612–617. 2 indexed citations
20.
Leijonmarck, C.-E., L. Bergstrand, B. Carlstedt‐Duke, et al.. (1988). Total Parenteral Nutrition and the Function of the Intestinal Microflora in Crohn's Disease. Scandinavian Journal of Gastroenterology. 23(1). 59–64. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026